NaiyerRizvi
Latest
China completes first human trial with CRISPR-edited genes
As predicted, it happened: On October 28th, Chinese oncologists at Sichuan University were the first in the world to insert CRISPR-modified cells into a patient suffering from an aggressive form of lung cancer, according to Nature. The journal reports that this first round of treatment in a safety trial went well enough to warrant a second injection of the Cas9-edited cells, and that nine more people will undergo the treatments in the future. From there, the patients will be monitored for at least six months, if not longer, to "determine whether the injections are causing serious adverse effects."
